Telaprevirbased triple therapy following partial splenic arterial embolization for chronic hepatitis C with thrombocytopenia can reduce carcinogenesis and improve hepatic function reserve

Author：                  

Publisher： Spandidos Publications

E-ISSN： 1792-1015|10|4|1334-1338

ISSN： 1792-0981

Source： Experimental and Therapeutic Medicine, Vol.10, Iss.4, 2015-01, pp. : 1334-1338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plasma sphingolipids: Potential biomarkers for severe hepatic fibrosis in chronic hepatitis C

By                    

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 323-330

Spandidos Publications

Access to resources Recommend Favorite

Comparative efficacy and cost effectiveness of splenectomy and thrombopoietin prior to peginterferon and ribavirin therapy with compensatory cirrhosis associated with hepatitis C and thrombocytopenia

By              

Experimental and Therapeutic Medicine, Vol. 10, Iss. 6, 2015-01 ,pp. : 2180-2186

Spandidos Publications

Access to resources Recommend Favorite

Superselective internal iliac arterial embolization for severe hemorrhage following radical prostatectomy

By              

Oncology Letters, Vol. 4, Iss. 3, 2012-01 ,pp. : 521-523

Spandidos Publications

Access to resources Recommend Favorite

Hepatic arterial administration of ginsenoside Rg3 and transcatheter arterial embolization for the treatment of VX2 liver carcinomas

By        

Experimental and Therapeutic Medicine, Vol. 5, Iss. 3, 2013-01 ,pp. : 761-766

Spandidos Publications

Access to resources Recommend Favorite

Screening for serum biomarkers in patients with chronic hepatitis B with hepatitis B surface antigen seroclearance, following pegylated interferon alpha therapy

By  

Molecular Medicine Reports, Vol. 11, Iss. 1, 2015-01 ,pp. : 427-433

Spandidos Publications

Access to resources Recommend Favorite